Understanding Triterras Current and Future Valuation, page-74

Just noticing there are competitors in fast COVID testing coming to market..........
https://www.anteotech.com/announcements/test-platform-and-covid-19-test-receive-ce-mark-approval/
https://www.pharmiweb.com/press-release/2021-03-29/instant-covid-tests-london-to-launch-first-test-centre-using-20-second-virolens-technology
Re
@sparkster

I continue to believe that BRN's key prime mover advantage is just where BRN's brains trust have been saying:
1. With SNN
2. Without reference to the cloud for computing support for decision making (but downloading new models and providing feedback is not ruled out).
3. With (as in-- as well as above) CNN which is amenable to conversion to SNN as has been described in BRN documents and announcements.

BRN Akida isn't going to replace mainframe/cloud business computing (payroll etc), or graphics/GPU matrix computation.
I am still unclear on the emanating potential from BRN/Renesas. I haven't seen anything concrete on its scope, other than there is a relationship.
@BarrelSitter
cited Valeo relationship potential a couple of posts back.
That's IMO where the significant action may be.
DYOR.